Loading...

Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 55.55 EUR -0.7% Market Closed
Updated: Mar 25, 2023

Relative Value

The Relative Value of one BAYN stock under the Base Case scenario is 94.39 EUR. Compared to the current market price of 55.55 EUR, Bayer AG is Undervalued by 41%.

Relative valuation is one of two methods of placing a monetary value on a company; the other is Discounted Cash Flow valuation method. We use a combination of these two methods to calculate the Intrinsic Value of stock as accurately as possible.

BAYN Relative Value
Base Case
94.39 EUR
Undervaluation 41%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

Median 1.1
Industry 2.8
Forward Multiple 1.1
Median 11.5
Industry 22.9
Forward Multiple 7.4
Median 8.3
Industry 17.6
Forward Multiple N/A
Median 16.3
Industry 22.6
Forward Multiple N/A
Median 1.4
Industry 2.1
Forward Multiple N/A
Median 12.3
Industry 15.2
Forward Multiple N/A
Median 0.7
Industry 2.1
Forward Multiple N/A

Multiples Across Competitors

BAYN Competitors Multiples
Bayer AG Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
DE
Bayer AG
XETRA:BAYN
54.6B EUR 1.1 13.2 5.8 11.1
ZA
Aspen Pharmacare Holdings Ltd
JSE:APN
8T Zac 0 0 0 0
US
Johnson & Johnson
NYSE:JNJ
476B USD 5 26.5 14.4 18.2
DK
Novo Nordisk A/S
NYSE:NVO
348B USD 13.6 43.4 29.4 32.3
US
Eli Lilly and Co
NYSE:LLY
319B USD 11.2 51.1 33.9 40.1
US
Merck & Co Inc
NYSE:MRK
266B USD 4.5 18.3 11.6 13.9
US
Pfizer Inc
NYSE:PFE
227B USD 2.3 7.2 5.6 6.3
CH
Roche Holding AG
SIX:ROG
206B CHF 3.2 14.1 9.2 11.1
UK
AstraZeneca PLC
LSE:AZN
172B GBP 4.7 63.9 142.2 235.8
CH
Novartis AG
SIX:NOVN
162B CHF 3.4 25.4 8.9 13.8
US
Bristol-Myers Squibb Co
NYSE:BMY
140B USD 3 22.2 7.6 14.3

See Also

Similar Stocks